ALSO NOTED: Perrigo, Teva get clearance for generic Zyrtec-D; Pfizer sues Impax over copycat Detrol;

> Perrigo and its partner Teva Pharmaceutical Industries got the FDA nod for their over-the-counter version of McNeil Consumer Healthcare's Zyrtec-D; McNeil, a Johnson & Johnson unit, launched its OTC version in January. Report

> Pfizer sued Impax Laboratories over the latter's plans to launch a generic competitor to the overactive-bladder med Detrol LA. Report

> A Connecticut bill that would limit drug makers' gifts to doctors is languishing in the state legislature. Report

> APP Pharmaceuticals reported a 70 percent drop in fourth-quarter profits to $8.5 million on revenues of $194.6 million. Report

Most popular article this week: Schering-Plough slashes jobs. Report

And Finally... Even fictional drugs can cause controversy, as a British TV drama discovered the hard way. Report

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.